Valeria Cnossen
Conseiller Juridique Général chez GALAPAGOS NV
Postes actifs de Valeria Cnossen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GALAPAGOS NV | Conseiller Juridique Général | 01/01/2023 | - |
Historique de carrière de Valeria Cnossen
Anciens postes connus de Valeria Cnossen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Johnson & Johnson Consumer NV | Corporate Officer/Principal | - | - |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Compliance Officer | - | - |
| Conseiller Juridique Général | - | - |
Statistiques
Internationale
| Belgique | 3 |
| Pays-Bas | 2 |
Opérationnelle
| General Counsel | 2 |
| Compliance Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GALAPAGOS NV | Health Technology |
| Entreprise privées | 2 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
| Johnson & Johnson Consumer NV |
- Bourse
- Insiders
- Valeria Cnossen
- Expérience
